Influence of Xiaoke Tongguan Decoction on High Mobility Group Protein-1 and Serum Retinal Element 1 Level in Patients with Diabetes United Coronary Heart Disease
|更新时间:2024-01-04
|
Influence of Xiaoke Tongguan Decoction on High Mobility Group Protein-1 and Serum Retinal Element 1 Level in Patients with Diabetes United Coronary Heart Disease
Chinese Journal of Experimental Traditional Medical FormulaeVol. 21, Issue 3, Pages: 191-195(2015)
HUANG Xue-lian, WEI Yu-na, MA Feng-ying, et al. Influence of Xiaoke Tongguan Decoction on High Mobility Group Protein-1 and Serum Retinal Element 1 Level in Patients with Diabetes United Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(3): 191-195.
DOI:
HUANG Xue-lian, WEI Yu-na, MA Feng-ying, et al. Influence of Xiaoke Tongguan Decoction on High Mobility Group Protein-1 and Serum Retinal Element 1 Level in Patients with Diabetes United Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(3): 191-195. DOI: 10.13422/j.cnki.syfjx.2015030191.
Influence of Xiaoke Tongguan Decoction on High Mobility Group Protein-1 and Serum Retinal Element 1 Level in Patients with Diabetes United Coronary Heart Disease
Objective: To discuss the curative efficacy of Xiaoke Tongguan decoction (XTD) combined conventional western medicine therapy in treating diabetes united coronary heart disease and to explore its influence on high mobility group protein B1 (HMGB 1) and serum retinal element 1 level. Method: Ninety-two patients were randomly divided into the control group (46 cases) and the combination group (46 cases) by random number table. Patients in the control group received western medicine comprehensive treatment including controlling blood glucose and blood pressure
aspirin enteric-coated tablets
0.1 g
once daily
metoprolol tartrate tablets
50 mg
once daily
simvastatin tablets
10 mg
once daily and nitroglycerin tablets
0.5 mg
sublingually taken when necessary. Based on the treatment in the control group
patients in the combination group added XTD
1 does daily. All patients received 3-month treatment. Levels of fasting blood glucose (FBG)
fasting insulin (FINS)
glycosylated hemoglobin (HbAlc)
HMGB 1 and serum visfatin 1 were tested. The insulin resistance index (HOMA-IR) was calculated and the electrocardiographic examination was performed before and after treatment. The anginal attacks and nitroglycerin dosage were recorded during observation period. The blood fat and score of Qi and Yin deficiency and blood stasis syndrome were tested. Result: After treatment
the efficient rate of the combination group was 96.65%
which was superior to 80.43% in control group (P<0.05). Levels of FINS
HOMA-IR and HbAlc in the combination group were less than those in control group (P<0.01). Cases of restoring normal with TG and HDL-C in the combination group were higher than those in control group (P<0.05). The number of angina pectoris attack each week and the dosage of nitroglycerin in the combination group were lower than those in control group (P<0.01). Nitroglycerin stopped reduction rate was 84.8% in the combination group
which was more than the rate of 65.2% in control group (P<0.05). Serum HMGB1 in both groups declined compared with the data before treatment. Besides
the degree of declining in the combination group was lower than that in control group (P<0.01). Level of serum retinal element 1 in both groups went up as compared with the data before treatment
while the risen degree in the combination group was higher than that in control group (P<0.01). Conclusion: On the basis of conventional western medicine treatment
adding XTD coud improve insulin resistance
enhance insulin sensitivity
regulate lipid metabolism
improve the symptoms of coronary heart disease. Its action mechanism may be related to reducing proinflammatory meson HMGB1 and enhancing the level of serum retinal element 1.
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation
Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway
Construction of an Intelligent Diagnosis and Treatment Ontology for Traditional Chinese Medicine Based on Clinical Practice Guidelines:A Case Study of Coronary Heart Disease
Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome
Related Author
HU Longxiao
GAO Jiabei
MA Weihao
LU Jieming
GAO Yunxiao
YUAN Yue
ZHANG Qiuyan
CHEN Xiaoxiao
Related Institution
Natural History Museum of China
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences
School of Clinical Medicine,Beijing University of Chinese Medicine
Institute of Basic Medical Sciences,Xiyuan Hospital,China Academy of Chinese Medical Sciences